Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a positive skin prick test or a blood test showing an allergic response, regardless of what they are allergic to
- People who are being investigated for a possible allergic condition, where a doctor has recommended a skin prick test, allergy blood test, or a supervised food or medication reintroduction test as part of their care
- People who have been diagnosed with systemic or cutaneous mastocytosis (a condition involving an abnormal build-up of certain immune cells in the body or skin) according to international classification guidelines
- People who have been diagnosed with mast cell activation syndrome (a condition where certain immune cells release too many chemicals, causing widespread symptoms) according to international classification guidelines
- People who have a family-linked condition called familial hyper-alpha tryptasemia, identified by a specific genetic variation in the TPSAB1 gene
- People who have asthma of any level of severity
- People who are members of, or covered by, a French social security scheme
- People who are able to understand the study information, have no restriction of legal rights by judicial authorities, have a sufficient understanding of French, and have given written consent to participate before any samples or data are collected
Who may not be able to join:
- People who are under a legal protection order, guardianship, or curatorship
- People who are pregnant or breastfeeding at the time of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laurent GUILLEMINAULT, MD, University Hospital, Toulouse
Phone: 05 67 77 17 51
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Biobanking for Biomarkers In Respiratory Disease, Allergic diseases and/or mast cell disorders
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.